Status:

COMPLETED

Assess the Influence of Nicotine Flux and Nicotine Form on Subjective Effects Related to Dependency

Lead Sponsor:

American University of Beirut Medical Center

Collaborating Sponsors:

National Institutes of Health (NIH)

National Institute on Drug Abuse (NIDA)

Conditions:

Nicotine Vaping

Nicotine Dependence

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Electronic nicotine delivery systems (ENDS) heat and vaporize a nicotine-containing liquid to produce an aerosol that can deliver nicotine to the blood and the brain. ENDS use has increased rapidly in...

Detailed Description

Assess the influence of nicotine flux and nicotine form on subjective effects. At AUB, the investigators will assess subjective effects (e.g. product liking, nicotine craving) and puffing topography f...

Eligibility Criteria

Inclusion

  • Must be healthy and above 18 years of age
  • Must be willing to provide informed consent, attend the lab, and abstain from tobacco/nicotine as required (participants will be instructed to abstain from nicotine/tobacco and/or ENDS use for ≥12h)
  • A dual ENDS and tobacco user who reports daily use of ENDS (≥ 3 mg/ml nicotine) or cigarettes (any frequency) AND someday use (≥ 3 days/week) of ENDS (≥ 3 mg/ml nicotine) or cigarettes (any frequency) for the past 3 months or longer

Exclusion

  • History of chronic disease or an uncontrolled psychiatric condition
  • History of or active cardiovascular disease, low/high blood pressure, seizures, regular use of a prescription medication (except vitamins/birth control)
  • Past month use of cocaine, opioids, benzodiazepines, or methamphetamines
  • Individuals who report using marijuana \>15/30 days
  • Women will be excluded if they are breast-feeding or pregnant
  • Participants intending to quit tobacco/nicotine use in the next 30 days and referred to cessation treatment

Key Trial Info

Start Date :

July 13 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 11 2025

Estimated Enrollment :

130 Patients enrolled

Trial Details

Trial ID

NCT05430334

Start Date

July 13 2022

End Date

July 11 2025

Last Update

July 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

American University of Beirut

Beirut, Lebanon, 11-0236